SLC29A2
Basic information
Region (hg38): 11:66362521-66372214
Previous symbols: [ "ENT2", "HNP36" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC29A2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 0 |
Variants in SLC29A2
This is a list of pathogenic ClinVar variants found in the SLC29A2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-66363470-G-T | not specified | Uncertain significance (Dec 16, 2023) | ||
11-66363516-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
11-66364286-T-C | not specified | Uncertain significance (Aug 22, 2023) | ||
11-66364346-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
11-66364408-C-T | not specified | Uncertain significance (Feb 23, 2023) | ||
11-66364409-G-A | not specified | Uncertain significance (Jun 12, 2023) | ||
11-66366171-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
11-66366180-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
11-66366466-G-C | not specified | Uncertain significance (Apr 09, 2024) | ||
11-66366557-G-T | not specified | Uncertain significance (Dec 18, 2023) | ||
11-66367477-C-G | not specified | Uncertain significance (Jun 21, 2022) | ||
11-66367508-G-A | not specified | Uncertain significance (Jun 13, 2023) | ||
11-66367852-T-A | not specified | Uncertain significance (Jun 02, 2023) | ||
11-66367855-C-T | not specified | Uncertain significance (Mar 17, 2023) | ||
11-66367866-C-T | not specified | Uncertain significance (Nov 28, 2023) | ||
11-66368548-A-C | not specified | Uncertain significance (Mar 08, 2024) | ||
11-66368554-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
11-66368602-A-T | not specified | Uncertain significance (Dec 14, 2021) | ||
11-66368608-C-G | not specified | Uncertain significance (Jun 11, 2021) | ||
11-66369080-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
11-66369081-C-A | not specified | Uncertain significance (Feb 17, 2024) | ||
11-66369104-C-G | not specified | Uncertain significance (Jan 26, 2023) | ||
11-66369182-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
11-66369468-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
11-66369522-G-A | not specified | Uncertain significance (Feb 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC29A2 | protein_coding | protein_coding | ENST00000357440 | 12 | 9694 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.23e-14 | 0.0210 | 125658 | 0 | 90 | 125748 | 0.000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.481 | 236 | 258 | 0.916 | 0.0000155 | 2924 |
Missense in Polyphen | 89 | 106.37 | 0.83668 | 1235 | ||
Synonymous | 1.46 | 102 | 123 | 0.832 | 0.00000829 | 977 |
Loss of Function | 0.0846 | 21 | 21.4 | 0.980 | 0.00000102 | 229 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000537 | 0.000536 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000601 | 0.000598 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000662 | 0.0000653 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine. {ECO:0000269|PubMed:9396714}.;
- Pathway
- Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Thioguanine Action Pathway;Mercaptopurine Metabolism Pathway;Purine metabolism;Transport of vitamins, nucleosides, and related molecules;SLC-mediated transmembrane transport;Transport of small molecules;Pyrimidine metabolism;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
(Consensus)
Recessive Scores
- pRec
- 0.171
Intolerance Scores
- loftool
- 0.526
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 18.06
Haploinsufficiency Scores
- pHI
- 0.534
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.613
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.756
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc29a2
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype;
Gene ontology
- Biological process
- nucleobase-containing compound metabolic process;cell population proliferation;adenine transport;guanine transport;nucleoside transport;uridine transport;hypoxanthine transport;thymine transport;neurotransmitter reuptake;nucleoside transmembrane transport
- Cellular component
- nucleolus;plasma membrane;integral component of plasma membrane;basolateral plasma membrane;nuclear membrane;presynapse
- Molecular function
- nucleoside transmembrane transporter activity